You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0194 Long Term Safety for Tocilizumab in Real-World Setting; 3 Year Follow-Up Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0194 Long Term Safety for Tocilizumab in Real-World Setting; 3 Year Follow-Up Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yamamoto K, Goto H, Hirao K, et al
SAT0194 Long Term Safety for Tocilizumab in Real-World Setting; 3 Year Follow-Up Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
Annals of the Rheumatic Diseases 2015;74:725-726.